MiR-27a-3p Targeting GSK3ß Promotes Triple-Negative Breast Cancer Proliferation and Migration Through Wnt/ß-Catenin Pathway.

Wu, Ruizhen; Zhao, Bingqing; Ren, Xunxin; Wu, Shiheng; Liu, Mingzao; Wang, Zipeng; Liu, Wei.

Afiliação

Wu R; The First Affiliated Hospital, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Zhao B; The First Affiliated Hospital, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Ren X; The First Affiliated Hospital, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Wu S; The First Affiliated Hospital, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Liu M; The First Affiliated Hospital, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Wang Z; The First Affiliated Hospital, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.
Liu W; The First Affiliated Hospital, School of Clinical Medicine, Guangdong Pharmaceutical University, Guangzhou, People's Republic of China.

Cancer Manag Res ; 12: 6241-6249, 2020.

Article em En | MEDLINE | ID: mdl-32801869